Loading clinical trials...
Loading clinical trials...
N2015-01: Neuroblastoma Precision Trial
Conditions
Interventions
Gene panel sequencing of tumor specimens
Locations
11
United States
Children's Hospital Los Angeles
Los Angeles, California, United States
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
Children Hospital of Colorado
Aurora, Colorado, United States
Children's Healthcare of Atlanta
Atlanta, Georgia, United States
Children's Memorial Hospital - Chicago
Chicago, Illinois, United States
Childrens Hospital Boston, Dana-Farber Cancer Institute.
Boston, Massachusetts, United States
Start Date
August 22, 2016
Primary Completion Date
December 1, 2025
Completion Date
December 1, 2025
Last Updated
February 17, 2025
NCT04936529
NCT06541262
NCT04851119
NCT03363373
NCT05890781
NCT03050268
Lead Sponsor
New Approaches to Neuroblastoma Therapy Consortium
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions